Strober B, Imafuku S, Paul C, Gooderham M, Spelman L, Seo SJ, Passeron T, Hoyt K, Colombo MJ, Banerjee S, Augustin M, Stein Gold L, Alexis AF, Thaci D, Lebwohl M, Issa NT, Cameron MC. Deucravacitinib in Plaque Psoriasis: Maintenance of Response Over 4 Years in the Phase 3 POETYK PSO-1, PSO-2, and LTE Trials. J of Skin [Internet]. 2024Jul.23 [cited 2024Jul.23];8(4):s407. Available from: https://jofskin.org/index.php/skin/article/view/2856